Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

AZD5305 hADME in Patients With Advanced Solid Malignancies — Stella

Home/Locally Advanced or Metastatic Solid Tumor/AZD5305 hADME in Patients With Advanced Solid Malignancies

View on ClinicalTrials.gov

Recruiting

Back to Locally Advanced or Metastatic Solid Tumor trials

AZD5305 hADME in Patients With Advanced Solid Malignancies

Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.

Trial locations(2 sites)

United Kingdom

Research Site, Liverpool

Research Site, Manchester

Key details

Phase

Early testing

Sponsor

AstraZeneca

Collaborators

Fortrea

Enrollment target

~8 participants

Started

April 2025

Primary completion

October 2026

Age range

18 Years and older

Last updated March 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.